Back
Guardant Health, Inc. 10K Form
Buy
56
GH
Guardant Health, Inc.
Last Price:
$108.51
Seasonality Move:
-2.13%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
10K form not available
Receive GH News And Ratings
See the #1 stock for the next 7 days that we like better than GH
GH Financial Statistics
Sales & Book Value
| Annual Sales: | $739M |
|---|---|
| Cash Flow: | $-45.8M |
| Price / Cash Flow: | 0 |
| Annual Sales: | $-2.84 |
| Price / Book: | 32.59 |
Profitability
| EPS (TTM): | -3.21310 |
|---|---|
| Net Income (TTM): | $-398.8M |
| Gross Margin: | $449.2M |
| Return on Equity: | -8518.58% |
| Return on Assets: | -28.58% |
Guardant Health, Inc. Earnings Forecast
Key Guardant Health, Inc. Financial Ratios
-
The Gross Profit Margin over the past 9 years for GH is 60.79%.
-
The Selling, General & Administrative Expenses for GH have been equal to 73.75% of Gross Profit Margin.
-
The Research & Development expenses have been 47.06% of Revenue.
-
The Net Earning history of GH is -59.05% of Total Revenues.
-
Per Share Earnings over the last 9 years have been positive in 3 years.
Guardant Health, Inc. Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NASDAQ |
|---|---|
| Industry: | Health Care Providers & Services |
| Sector: | Health Care |
| Current Symbol: | GH |
| CUSIP: | 40131M |
| Website: | guardanthealth.com |
Debt
| Debt-to-Equity Ratio: | -3.74 |
|---|---|
| Current Ratio: | 3.5 |
| Quick Ratio: | 2.94 |
Price-to-Earnings
| Trailing P/E Ratio: | 0 |
|---|---|
| Forward P/E Ratio: | 0 |
GH Technical Analysis vs Fundamental Analysis
Buy
56
Guardant Health, Inc. (GH)
is a Buy
Is Guardant Health, Inc. a Buy or a Sell?
-
Guardant Health, Inc. stock is rated a BuyThe current Guardant Health, Inc. [GH] share price is $108.52. The Score for GH is 56, which is 12% above its historic median score of 50, and infers lower risk than normal.